BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells

Abstract

To the editor: Montes-Moreno et al recently reported the usefulness of SPIB as a novel immunohistochemical marker for supporting the diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN).[1][1] The article highlights the well-recognized difficulty in approaching the diagnosis of BPDCN,